pargyline and l 365260

pargyline has been researched along with l 365260 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fink, H; Marsden, CA; Morgenstern, R; Reum, T; Schäfer, U	1

Other Studies

1 other study(ies) available for pargyline and l 365260

Article	Year
Cholecystokinin increases extracellular dopamine overflow in the anterior nucleus accumbens via CCK(B) receptors in the VTA assessed by in vivo voltammetry. Neuropeptides, 1997, Volume: 31, Issue:1 Topics: Animals; Benzodiazepinones; Cholecystokinin; Devazepide; Dopamine; Dose-Response Relationship, Drug; Electrophysiology; Extracellular Space; Hormone Antagonists; Male; Microinjections; Monoamine Oxidase Inhibitors; Nucleus Accumbens; Pargyline; Phenylurea Compounds; Rats; Rats, Wistar; Receptor, Cholecystokinin A; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Sincalide; Tetragastrin; Ventral Tegmental Area	1997

Article

Year

Cholecystokinin increases extracellular dopamine overflow in the anterior nucleus accumbens via CCK(B) receptors in the VTA assessed by in vivo voltammetry.

Neuropeptides, 1997, Volume: 31, Issue:1

Topics: Animals; Benzodiazepinones; Cholecystokinin; Devazepide; Dopamine; Dose-Response Relationship, Drug; Electrophysiology; Extracellular Space; Hormone Antagonists; Male; Microinjections; Monoamine Oxidase Inhibitors; Nucleus Accumbens; Pargyline; Phenylurea Compounds; Rats; Rats, Wistar; Receptor, Cholecystokinin A; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Sincalide; Tetragastrin; Ventral Tegmental Area

1997